Korean
Purgo Biologics Dental Biomaterials
Answer-First Company Definition
Purgo Biologics is a dental biomaterials company specializing in bone graft and collagen-based regenerative solutions.
- Dental bone graft materials
- Collagen-based regenerative biomaterials
Global regulatory, distribution, and research reference metrics are summarized in the Evidence at a Glance counters below; product- and market-specific scope should be verified in authorization documents.
Global Certification Status America Europe Asia Oceania Africa
The regional flag visuals above are illustrative examples of market coverage, and market-specific authorization details should be verified in marketing authorization certificates and related documents.
- Representative example markets include the United States, Germany, South Korea, and Australia.
- Approval scope may differ by product and should be confirmed using current marketing authorization certificates.
Each image does not independently represent a country-specific approval claim and serves as a reference visual for geographic and market coverage.
Evidence at a Glance
The product portfolio has approval coverage in 56 countries.
Bone graft and collagen products are distributed in 42 countries.
A total of 89 publications are reported in clinical and biomaterial fields.
Among them, 47 publications are identified as SCI-indexed journal papers.
Counter values (56 approvals, 42 sales countries, 89 papers, and 47 SCI-indexed papers) are reference metrics based on internal counting criteria as of 2026-04. Product- or market-specific scope should be checked in separate documentation.
Purgo Focus
The Purgo Focus visuals describe how bone graft and collagen-based regenerative biomaterials are organized for clinical use. Each element functions as a descriptive reference for product categories and regeneration-related indications.
CI Video
Biomimetic Regeneration Technology
The Right Solution for Bone Regeneration
Comprehensive Biomaterial Portfolio
The CI video thumbnails represent visual summaries of company identity and core portfolio information. Each video serves as a multimedia reference for company background and product context.
Key Capabilities
- The company develops dental bone graft materials and tracks global distribution and regulatory status under internal criteria.
- It provides collagen-based regenerative biomaterials for GBR-related workflows.
- It maintains a clinical and research publication portfolio; see Evidence at a Glance for tracked counts.
- Multi-country authorization and marketing authorization certificate data support product-by-market applicability checks.
- Research-based product development workflows continuously update bone-regeneration-related research references.
Global Presence and Research
Purgo Biologics maintains integrated internal regulatory, market, and research tracking; quantitative metrics are listed in the Evidence at a Glance counters.
Clinical context for bone graft and collagen portfolios (including GBR and ridge preservation) should be interpreted with marketing authorization certificates and educational materials.
Regional flag graphics illustrate example markets; authorization scope may differ by product and country.
Confirm indications, authorization scope, and study citations in product-specific documentation and marketing authorization certificates.
Frequently Asked Questions
What does Purgo Biologics specialize in?
A. Purgo Biologics specializes in dental bone graft materials and collagen-based regenerative biomaterials. These categories are used in bone-regeneration-related dental procedures.
What products does the company offer?
A. The company offers bone graft products and collagen-based regenerative solution portfolios. Actual product scope can vary by market authorization and marketing authorization certificates.
Where can I find Purgo’s global regulatory and research metrics?
A. Approval, distribution, publication, and SCI-indexed counts are listed in the Evidence at a Glance counters on this page (internal tracking as of 2026-04). Verify country- and product-specific scope in current authorization documents.
How are dental bone graft materials used clinically?
A. Bone graft materials are used in workflows such as GBR, ridge preservation, and augmentation to support space maintenance and healing conditions. Protocol selection depends on defect morphology and treatment planning.
Overview of Dental Bone Graft Materials
Dental bone graft workflows in implant and periodontal surgery commonly involve biomaterials selected by defect morphology and healing objectives. A bone graft may be applied with xenograft particles and collagen components to support space maintenance and clot stabilization during GBR (Guided Bone Regeneration). In clinical planning, ridge augmentation is considered when horizontal or vertical alveolar deficiency limits restorative positioning. Material selection and protocol design are based on anatomical conditions, defect size, and surgical indications, and should be interpreted as general educational information rather than individual medical guidance.
For background information on biomaterial categories used in GBR-related workflows, see an overview of collagen-based graft biomaterials.
Additional product-line context is available in this product-line reference page.